Inhibikase Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-SP IKT HOLDINGS LLC(8.69%),SP Soleus Holdings LLC(8.69%)
Inhibikase Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Soleus Private Equity Fund III, L.P.(9.99%),Soleus Private Equity GP III, LLC(9.99%), etc.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more